APO RESEARCH · REPORT
Sphingosine 1-Phosphate Receptor 1
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Product & engineering
Understand the product.
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Selected research
Market Structure
Global Sphingosine 1-Phosphate Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.
This report provides an overview of the global Sphingosine 1-Phosphate Receptor 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Sphingosine 1-Phosphate Receptor 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sphingosine 1-Phosphate Receptor 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sphingosine 1-Phosphate Receptor 1 market size, projected growth trends, production technologies, key applications, and end-use industries.
Sphingosine 1-Phosphate Receptor 1 Segment by Company
Novartis AG
Bristol-Myers Squibb Company
Sphingosine 1-Phosphate Receptor 1 Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Application
Hospital
Clinic
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sphingosine 1-Phosphate Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine 1-Phosphate Receptor 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sphingosine 1-Phosphate Receptor 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sphingosine 1-Phosphate Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sphingosine 1-Phosphate Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sphingosine 1-Phosphate Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fingolimod
- Siponimod
- Ozanimod
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis AG
- Bristol-Myers Squibb Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sphingosine 1-Phosphate Receptor 1 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sphingosine 1-Phosphate Receptor 1 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sphingosine 1-Phosphate Receptor 1 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sphingosine 1-Phosphate Receptor 1 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sphingosine 1-Phosphate Receptor 1 Market Dynamics
- 2.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends
- 2.2 Sphingosine 1-Phosphate Receptor 1 Industry Drivers
- 2.3 Sphingosine 1-Phosphate Receptor 1 Industry Opportunities and Challenges
- 2.4 Sphingosine 1-Phosphate Receptor 1 Industry Restraints
3 Sphingosine 1-Phosphate Receptor 1 Market by Manufacturers
- 3.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Manufacturers (2021-2026)
- 3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Manufacturers (2021-2026)
- 3.3 Global Sphingosine 1-Phosphate Receptor 1 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sphingosine 1-Phosphate Receptor 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sphingosine 1-Phosphate Receptor 1 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers, Product Type & Application
- 3.7 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sphingosine 1-Phosphate Receptor 1 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sphingosine 1-Phosphate Receptor 1 Players Market Share by Revenue in 2025
- 3.8.3 2025 Sphingosine 1-Phosphate Receptor 1 Tier 1, Tier 2, and Tier 3
4 Sphingosine 1-Phosphate Receptor 1 Market by Type
- 4.1 Sphingosine 1-Phosphate Receptor 1 Type Introduction
- 4.1.1 Fingolimod
- 4.1.2 Siponimod
- 4.1.3 Ozanimod
- 4.1.4 Other
- 4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type
- 4.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 4.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2021-2032)
- 4.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type
- 4.3.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 4.3.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Type (2021-2032)
5 Sphingosine 1-Phosphate Receptor 1 Market by Application
- 5.1 Sphingosine 1-Phosphate Receptor 1 Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application
- 5.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 5.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2021-2032)
- 5.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application
- 5.3.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 5.3.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Application (2021-2032)
6 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region
- 6.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2021-2032)
- 6.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2021-2026)
- 6.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region
- 7.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region
- 7.1.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2021-2026)
- 7.1.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2027-2032)
- 7.1.4 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sphingosine 1-Phosphate Receptor 1 Revenue (2021-2032)
- 7.2.2 North America Sphingosine 1-Phosphate Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sphingosine 1-Phosphate Receptor 1 Revenue (2021-2032)
- 7.3.2 Europe Sphingosine 1-Phosphate Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis AG
- 8.1.1 Novartis AG Company Information
- 8.1.2 Novartis AG Business Overview
- 8.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 8.1.5 Novartis AG Recent Developments
- 8.2 Bristol-Myers Squibb Company
- 8.2.1 Bristol-Myers Squibb Company Company Information
- 8.2.2 Bristol-Myers Squibb Company Business Overview
- 8.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 8.2.5 Bristol-Myers Squibb Company Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sphingosine 1-Phosphate Receptor 1 Value Chain Analysis
- 9.1.1 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sphingosine 1-Phosphate Receptor 1 Production Mode & Process
- 9.2 Sphingosine 1-Phosphate Receptor 1 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sphingosine 1-Phosphate Receptor 1 Distributors
- 9.2.3 Sphingosine 1-Phosphate Receptor 1 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst